Patents by Inventor Eric L. Powell

Eric L. Powell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR SELECTION OF CHEMOTHERAPEUTIC AGENTS FOR ADENOCARCINOMA CANCER
    Publication number: 20130116209
    Abstract: The subject invention relates to determining the presence and level of hENT1 expression in tumor tissue that is appropriate for gemcitabine therapy, and more importantly, the level of hENT1 expression that signifies that treatment with a gemcitabine derivative is a more appropriate strategy.
    Type: Application
    Filed: August 2, 2012
    Publication date: May 9, 2013
    Applicants: VENTANA MEDICAL SYSTEMS, INC., CLOVIS ONCOLOGY, INC.
    Inventors: Jeffrey Dean Isaacson, Mical Raponi, James Ranger-Moore, Eric L. Powell
  • METHOD FOR SELECTION OF CHEMOTHERAPEUTIC AGENTS FOR ADENOCARCINOMA CANCER
    Publication number: 20130115628
    Abstract: The subject invention relates to determining the presence and level of hENT1 expression in tumor tissue that is appropriate for gemcitabine therapy, and more importantly, the level of hENT1 expression that signifies that treatment with a gemcitabine derivative is a more appropriate strategy.
    Type: Application
    Filed: August 2, 2012
    Publication date: May 9, 2013
    Applicants: VENTANA MEDICAL SYSTEMS, INC., CLOVIS ONCOLOGY, INC.
    Inventors: Jeffrey Dean Isaacson, Mical Raponi, James Ranger-Moore, Eric L. Powell